0001209191-15-067054.txt : 20150820
0001209191-15-067054.hdr.sgml : 20150820
20150820130351
ACCESSION NUMBER: 0001209191-15-067054
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150818
FILED AS OF DATE: 20150820
DATE AS OF CHANGE: 20150820
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ONCOGENEX PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000949858
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 954343413
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 19820 NORTH CREEK PARKWAY
STREET 2: SUITE 201
CITY: BOTHELL
STATE: WA
ZIP: 98011
BUSINESS PHONE: 425-686-1500
MAIL ADDRESS:
STREET 1: 19820 NORTH CREEK PARKWAY
STREET 2: SUITE 201
CITY: BOTHELL
STATE: WA
ZIP: 98011
FORMER COMPANY:
FORMER CONFORMED NAME: SONUS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19950825
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bencich John
CENTRAL INDEX KEY: 0001477056
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 033-80623
FILM NUMBER: 151065900
MAIL ADDRESS:
STREET 1: 2401 FOURTH AVENUE, SUITE 1050
CITY: SEATTLE
STATE: WA
ZIP: 98121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-08-18
0
0000949858
ONCOGENEX PHARMACEUTICALS, INC.
OGXI
0001477056
Bencich John
19820 NORTH CREEK PARKWAY
SUITE 201
BOTHELL
WA
98011
0
1
0
0
CFO
Common Stock
2015-08-18
4
M
0
5000
0.00
A
5000
D
Common Stock
2015-08-18
4
S
0
1427
2.76
D
3573
D
Restricted Stock Unit (RSU)
2015-08-18
4
M
0
5000
0.00
D
Common Stock
5000
15000
D
Represents shares of common stock acquired upon settlement of the restricted stock units ("RSUs") listed in Table II.
Represents shares of common stock that have been sold by the issuer to satisfy the tax liability in connection with the settlement of RSUs.
Each restricted stock unit (RSU) represents a contingent right to receive one share of the issuer's common stock at settlement.
Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of: (i) each anniversary of August 12, 2014 and (ii) the first day thereafter during which the issuer's trading window is open.
The RSUs expire 30 days from the date they vest.
Sandra Thomson as attorney-in-fact for John Bencich
2015-08-20